← Leaderboards
Andrew N Hoofnagle
University Of Washington
$12,195,295
Attributed
$13,467,816
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,328,347 · 11
By mechanism
U19$5,484,901 · 4
U01$4,420,157 · 2
U2C$3,377,815 · 2
P30$1,532,533 · 2
R01$1,512,941 · 1
Top collaborators
- Michael J Maccoss3 shared
- Amanda G Paulovich3 shared
- Pei Wang3 shared
Most similar at University Of Washington
Same institution · by research overlap
- David A. D'alessio$11,554,583
- Joann G Elmore$17,641,997
- David Baker$22,630,205
- Rona L. Levy$13,596,673
- Paul K Crane$33,412,303
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsLaboratoriesBiological MarkersAlzheimer&AposReproducibilityResearch PersonnelSamplingPlasmaProceduresValidationTandem Mass SpectrometryInterestLiquid ChromatographyEnsureMass Spectrum AnalysisResearch DesignSpecificityReagentUniversitiesGuidelinesSerumUnited StatesMeasurementClinical Research
Grant awards (33)
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment$1,056,723
U2C · FY2025 · CA
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes$828,866
U01 · FY2025 · DK · contact PI
Core - Biomarker Reference Laboratory$446,142
U2C · FY2025 · CA · contact PI
Analytic Core$249,395
P30 · FY2025 · DK · contact PI
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment$1,011,318
U2C · FY2024 · CA
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes$848,497
U01 · FY2024 · DK · contact PI
Project 3: Development of multiplex assays for clinical monitoring of disease$608,188
U19 · FY2024 · AG · contact PI
Core 3: The Affinity Reagent Characterization Core$497,365
U19 · FY2024 · AG · contact PI
Analytic Core$256,694
P30 · FY2024 · DK · contact PI
Core - Biomarker Reference Laboratory$31,121
U2C · FY2024 · CA · contact PI
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes$867,679
U01 · FY2023 · DK · contact PI
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment$792,490
U2C · FY2023 · CA
Project 3: Development of multiplex assays for clinical monitoring of disease$608,188
U19 · FY2023 · AG · contact PI
Core 3: The Affinity Reagent Characterization Core$497,365
U19 · FY2023 · AG · contact PI
Analytic Core$256,362
P30 · FY2023 · DK · contact PI
Core - Biomarker Reference Laboratory$40,021
U2C · FY2023 · CA · contact PI
Project 3: Development of multiplex assays for clinical monitoring of disease$578,004
U19 · FY2022 · AG · contact PI
Core 3: The Affinity Reagent Characterization Core$484,685
U19 · FY2022 · AG · contact PI
Analytic Core$256,694
P30 · FY2022 · DK · contact PI
Project 3: Development of multiplex assays for clinical monitoring of disease$608,188
U19 · FY2021 · AG · contact PI
Quantifying proteins in plasma to democratize personalized medicine for patients with type 1 diabetes$527,952
U01 · FY2021 · DK · contact PI
Core 3: The Affinity Reagent Characterization Core$497,365
U19 · FY2021 · AG · contact PI
Quantifying proteins in plasma to democratize personalized medicine for patients with type 1 diabetes$274,854
U01 · FY2021 · DK · contact PI
Analytic Core$256,694
P30 · FY2021 · DK · contact PI
Project 3: Development of multiplex assays for clinical monitoring of disease$608,188
U19 · FY2020 · AG · contact PI
Quantifying proteins in plasma to democratize personalized medicine for patients with type 1 diabetes$535,727
U01 · FY2020 · DK · contact PI
Core 3: The Affinity Reagent Characterization Core$497,365
U19 · FY2020 · AG · contact PI
Analytic Core$256,694
P30 · FY2020 · DK · contact PI
Quantifying proteins in plasma to democratize personalized medicine for patients with type 1 diabetes$536,582
U01 · FY2019 · DK · contact PI
HDL and cardiovascular risk in chronic kidney disease$380,456
R01 · FY2015 · HL · contact PI
HDL and cardiovascular risk in chronic kidney disease$378,525
R01 · FY2014 · HL · contact PI
HDL and cardiovascular risk in chronic kidney disease$367,710
R01 · FY2013 · HL · contact PI
HDL and cardiovascular risk in chronic kidney disease$386,250
R01 · FY2012 · HL · contact PI